Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Jan 11, 2022
Date Accepted: Apr 1, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A Framework for Femtech: guiding principles for developing digital reproductive health tools in the United States
ABSTRACT
The United States has abysmal reproductive health indices that, in part, reflect stark inequities experienced by people of color and those with preexisting medical conditions. The growth of “femtech,” or technology-based solutions to women’s health issues in the public and private sectors, is promising; yet these solutions are often geared towards health literate, socioeconomically privileged, and relatively healthy white cis-women. In this viewpoint, we propose a set of guiding principles for building technologies that proactively identifies and addresses these critical gaps in health care for people from socially and economically marginalized populations who are capable of pregnancy, as well as those with serious chronic medical conditions. These guiding principles require that such technologies: 1) include community stakeholders in the design, development, and deployment of the technology, 2) are grounded in person-centered frameworks, and 3) address health disparities as a strategy to advance health equity and improve health outcomes.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.